Quantcast

Latest Hydromorphone Stories

2010-10-22 00:00:36

In the last twenty years, the misuse of opioid-type medications has become an alarming problem in American society. Using new, patented technologies, Highland can develop and produce pharmaceutical products in solid dose, oral tablets which cannot be crushed for inhalation and is highly resistant to extraction methods commonly used by drug abusers. Saint Louis, MO (PRWEB) October 21, 2010 Highland Pharmaceuticals (http://www.highlandpharma.com) announces the availability of an...

2010-08-09 08:52:00

Combination of Morphine plus Oxycodone IV Demonstrates Improved Analgesia and Tolerability Compared to IV Morphine SYDNEY and BEDMINSTER, N.J., Aug 9 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today positive results of its Phase 2 comparative proof-of-concept study to evaluate the efficacy and safety of its IV (intravenous) formulation of morphine plus oxycodone versus IV morphine alone for the treatment of moderate to severe post-operative pain in patients...

2010-06-22 10:38:00

BLUE BELL, Pa., June 22 /PRNewswire/ -- TheraQuest Biosciences, Inc., a clinical stage pain management company today unveiled its analgesic product pipeline. TheraQuest also announced the launch of its new corporate website at http://www.theraquestinc.com. Najib Babul, PharmD, President and Chief Executive Officer, said, "After a careful strategic review of our pipeline, we have realigned our development efforts to focus on chronic pain products with the largest market potential and...

d9bc860589bf040aec3e1b2ec85042b91
2010-06-18 06:20:00

According to a study by two governmental agencies, emergency room visits linked to prescription painkillers abuse have jumped 111 percent over a five-year period, a shocking increase that threatens the public health system in the United States. Emergency room visits involving abuse of painkillers such as oxycodone rose from 144,644 in 2004 to more than 305,850 in 2008, according to a study by the Substance Abuse and Mental Health Services Administration and the Centers for Disease Control...

2010-03-26 15:00:00

BRISTOL, Tenn., March 26 /PRNewswire-FirstCall/ -- ------------------------------------------------------------------------ | IMPORTANT | | CORRECTION | | OF DRUG | | INFORMATION | |...

2009-10-13 07:00:00

SOMERSET, N.J., Oct. 13 /PRNewswire/ -- Meda Pharmaceuticals Inc. today announced the launch of Onsolis(TM)( )(fentanyl buccal soluble film) in the U.S. for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. Onsolis uses an innovative drug delivery technology called BioErodible MucoAdhesive (BEMA(TM)), developed by BioDelivery...

2009-09-29 00:56:47

A Swedish researcher says drugs that may cause dose dumping, releasing medication in an unsafe manner in those who have drunk alcohol, need to be tested. Hans Lennernas, a professor in Biopharmaceutics at Uppsala University in Sweden, says some controlled release pills and capsules are susceptible to dose dumping. Lennernas says a formulation of the pain medication hydromorphone is one example of dose dumping. Testing revealed alcohol intake caused the risk of overdose and the medication has...

2009-09-23 13:52:35

Controlled release pills and capsules that show a tendency in the standard laboratory test toward "dose dumping" "” releasing their medicine in a faster and potentially unsafe manner in patients who have consumed alcohol "” should be withheld from the market until proven safe with testing in people. That's the conclusion of a review of existing studies in the September-October issue of ACS' Molecular Pharmaceutics, a bi-monthly journal. In the article, Hans Lennernäs analyzed...

2009-08-13 14:59:00

BRISTOL, Tenn., Aug. 13 /PRNewswire-FirstCall/ -- King Pharmaceuticals((R)), Inc. (NYSE: KG) today announced that the U.S. Food and Drug Administration (FDA) has approved EMBEDA(TM) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules for oral use, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. EMBEDA(TM) is the first FDA-approved...

2009-06-17 06:00:00

CONSHOHOCKEN, PA and VANCOUVER, BC, June 17 /PRNewswire/ - Neuromed Pharmaceuticals Ltd. announced today that its subsidiary Neuromed Development Inc., has sold the U.S. rights to its lead investigational drug candidate, Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII), to Covidien's subsidiary Mallinckrodt Inc. On March 23, 2009, Neuromed announced that Exalgo met the primary endpoint in a pivotal phase III clinical trial. On May 22, 2009, Neuromed submitted a response to an...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related